Mash premiere
Mohamed Abdallah possesses extensive experience in the pharmaceutical industry, currently serving as the Methodology & Stability Director at BIOMED for Pharmaceutical Industries since February 2022. Previously held the position of Methodology & Stability Manager at the same company and contributed to Mash Premiere as a Stability-and-Methodology Manager since November 2011. Key responsibilities include preparing stability study protocols, validation SOPs for analytical test methods, reviewing and assuring instrumental calibration, and approving validation and stability files for drug registration. Additionally, Mohamed has experience as the Head of Section Stability at Mash Premiere and worked as a Bioequivalence Analyst at the Egyptian Research and Development Company from January 2007 to November 2011.
This person is not in any teams
Mash premiere
1 followers
Our Vision To provide the market with “A Cure For Every Disease” and to become one of the top 10 leading pharmaceutical companies. Our Mission Mash Premiere is a leading pharmaceutical company in the Egyptian market aiming to improve the quality of life for the whole MENA Region and Africa, through the local manufacturing and development of the latest innovations in the worldwide pharmaceutical industry. Our Values A focus on quality, modernity, and our passion for putting the patient first are the most important pillars of our philosophy. Providing a safe and challenging working environment for all the Mash Premiere family. Giving back to the community by starting charitable initiatives that bring about noticeable positive change.